1440 Saint-Catherine St W Suite 205, Montreal, Quebec


(514) 867-4718


A team united around a common goal: to promote successful aging through innovative telehealth tools.

Ralph Benatar


Ralph Benatar - Chemist, MBA - has been in the high tech industry for over 35 years. He has held important positions in several companies.

Founder and co-president: OtolaneSoft Group.

Otolane is a virtual platform developed with the latest technological tools, Otolane meets the growing needs of the automotive industry.

President: Exchange Market Systems - EMS.
EMS is the first digital platform to offer online financial and stock market information to the majority of banks in Canada. Its clients include TD Greenline, E-trade, HSBC, TD Waterhouse, Hong Kong Bank, CIBC, National Bank. The company was acquired by Sungard, the largest Financial Services Institution in the United States.

Co-Chairman: Virtuel Age International, uMind.
Virtual Age International, uMind is recognized internationally as the leading company in the field of e-learning. Its clients include Hydro-Québec, Government of Alberta, Nova Bus, Novo Nordisk, STM, McGill University.

Chief Operating and Financial Officer: NHC Communications.
NHC Communication, listed on the Toronto Stock Exchange - market capitalization 400M - specializes in electronic switches for telephone companies. Its customers: Verizon, Bell South, France Telecom.

Shareholder and member of the management team: MuxLab.
For over 35 years, MUXLAB has been a leader in the design and production of connectivity solutions for audio, video and CCTV transmissions.

Shareholder and member of management: US Debt Ventures.
USDV specializes in the acquisition of ratings and mortgages from banking institutions. USDV has developed its own algorithms for risk assessment and management.

Olivier Beauchet

Research & Development Advisor

Dr. Olivier Beauchet is a full professor in the Faculty of Medicine at the University of Montreal and an assistant professor in the Department of Medicine at McGill University (Montreal, Quebec, Canada).

Geriatrician-Neurologist in the departments of Medicine and Geriatrics, he practices at the Institut Universitaire de Gériatrie de Montréal (IUGM).

A clinician-scientist, Dr. Beauchet directs the "Vulnerability & Longevity" clinical research laboratory at the IUGM research center. He is also a senior researcher at the Lady Davis Institute for Medical Research at the Jewish General Hospital.

An international expert on aging for more than 20 years, he has more than 334 international publications in peer-reviewed journals, including some 20 scientific articles cited more than 200 times. He is also recognized worldwide for his ability to initiate, structure and disseminate innovative clinical research with concrete impacts on the improvement of health, autonomy and quality of life of seniors.

A specialist in standardized geriatric assessment and action research, Dr. Olivier Beauchet conducts pragmatic research to serve seniors by repositioning them at the heart of solution development processes, to put them back on the path to successful aging.

As early as 2011, Dr. Beauchet became interested in telehealth made for and by seniors, by creating solutions based on self-assessment. He was also able to combine these solutions with artificial intelligence and innovative interventions. Among other things, he has developed decision-making algorithms based on neural networks that have surpassed all existing models for predicting recurrent falls in the elderly.

As an expert at the Quebec Ministry of Health and Social Services during the first wave of the pandemic due to COVID-19, Dr. Olivier Beauchet created, validated and deployed the clinical socio-geriatric assessment tool, called ESOGER, for homebound seniors. Recognized by the Ministry of Health and Social Services in Quebec and supported by the Guedj Report to the Ministry of Solidarity and Health in France, this tool is now a reference tool within the Support for the Autonomy of the Elderly (SAPA) program-services of the Quebec CUSSS and CIUSSS. Dr. Beauchet's research on ESOGER is continuing thanks to funding from the Fonds de Recherche du Québec en Santé, in order to improve this tool and make it more effective.

The solutions developed by iTeQ telehealth are directly based on Dr. Olivier Beauchet's research and expert advice, which allows us to offer seniors, their caregivers and the professionals who accompany them the most appropriate solutions that will receive their approval and allow them to age in good health with a good quality of life and socially active.

Guillaume Collard

CTO - Chief Technology Officer

Guillaume Collard created his first website with the beginnings of the web at the age of 12. At 15, he developed an artificial intelligence for a video game.

During his studies in cognitive sciences, neuropsychology & sociology, Guillaume became a double winner of a university computer science competition which gave him the impetus to build Code Lion, a web agency specialized in the development of complex medical applications.

Co-founder of the research and development laboratory Sentimens, Guillaume specializes in the design and development of innovative technological solutions combining Big Data and Artificial Intelligence.

As a technological partner of the McGill RUISSS Centre of Excellence on Longevity and of the IUGM research center's "Vulnerability & Longevity" laboratory, he leads and contributes to the technical development of the CARE and ESOGER solutions, alongside Dr. Olivier Beauchet and Kévin Galéry.

Kévin Galéry

Research & Development Advisor

Scientist and Gerontologist by training, with 15 years of experience in research project management, Kévin Galéry was for 7 years project director at the Gérontopôle Autonomie et Longévité, a French research center on aging.

Arriving in Quebec in 2018, Kévin served as Deputy Scientific Director of the Centre of Excellence on Longevity at RUISSS McGill for 3 years before becoming Deputy Director of the "Vulnerability & Longevity" research laboratory at the IUGM research center.

Since 2011, Kévin has worked with Dr. Beauchet and Guillaume Collard in the development of telehealth solutions based on self-assessment of seniors. He has participated in the creation and scientific validation of several assessment tools such as the Brief Geriatric Assessment, CESAM and ESOGER.


Our Mission

Our mission is to accompany seniors towards successful aging, that is, healthy, independent and with a good quality of life, using intelligent telehealth as a support.

Cyrille Launay

Research & Development Advisor

Dr. Cyrille Launay is an assistant professor and clinical researcher in the Department of Geriatric Medicine at the Jewish General Hospital.

In 2011, he was appointed Chief of Clinic of the Universities and Assistant of the Hospitals in the Department of Internal Medicine and Clinical Gerontology at the CHU Hospital in Angers, France.

In 2015, Dr. Launay joined the Division of Geriatric Medicine at the University of Lausanne as Chief of Clinic.

His passion for teaching led him to be responsible for the development of a geriatric e-learning platform, as well as to participate in the teaching of geriatrics to post-graduate students in the rehabilitation department of CHUV Lausanne.

After a three-year career in the Division of Geriatrics at the University of Lausanne, he arrived in Quebec in 2018 as a physician at the Institut Universitaire Gériatrique de Montréal.

Her passion and interest in geriatrics is also reflected in her doctoral thesis. His dissertation topic was the Brief Geriatric Assessment, a tool for predicting prolonged length of hospital stay. Dr. Launay's research focuses on the prediction of adverse health events in elderly hospitalized patients, with a focus on the emergency department. His main publications focus on the predictive performance of screening tools to provide the right care to the right patient at the right time.

During his career, he has participated in numerous international and national conferences and has published and reviewed over 100 scientific papers, as well as supervised numerous theses. He has also provided several training courses such as "Union Nationale de l'Aide, des soins et des services à domicile"; France Alzheimer, "les géronto-technologies", to name a few.

A member of the Young Hospital Geriatricians Association, as well as a member of the Canadian Geriatrics Society's Interest Group: Seniors and Emergencies, co-chair, Dr. Launay is committed to the idea of promoting the study of all aspects of aging, promoting progress in the field of wellness of the elderly, and promoting and encouraging the acquisition of clinical knowledge in the field of geriatrics.

Alain Ptito

Research & Development Advisor

Dr. Alain Ptito is a professor in the Department of Neurology and Neurosurgery at McGill University and a neuropsychologist and senior researcher at the Montreal Neurological Institute and Hospital and the Research Institute of the McGill University Health Centre (MUHC). Until recently (October 2020), he was Chair of the Department of Psychology at the MUHC.


Dr. Ptito's research program involves studying the mechanisms involved in brain reorganization and plasticity in hemispherectomized and callosotomized patients as well as in those with Parkinson's disease and acquired brain injuries, particularly stroke and head trauma. His clinical work includes neuropsychological assessment of these patients.

Dr. Ptito studied clinical psychology at McGill University (1975) and received graduate degrees in experimental psychology (1979) and neuropsychology (1986) from the Université de Montréal. His doctoral dissertation examined residual vision in the blind visual field of patients who have had a cerebral hemisphere removed. He is a member of the Ordre des Psychologues de la province de Québec and the Société des Experts en Évaluation Médicale Légale du Québec.

His research has been funded by CIHR, NSERC, FRQS, NFB-REPAR, CASM/NHL and the Heart and Stroke Foundation, the Marie-Robert Foundation and MITACS. In recent years, he has used functional magnetic resonance imaging (fMRI) to study motor recovery following stroke and the neural substrates of blind vision after hemispherectomy. He has also demonstrated that this technique, along with diffusion tensor imaging and evoked potentials, can be used to explore the neural mechanisms underlying traumatic brain injury, particularly in athletes. He and his research team have pointed out that there are abnormal activation patterns following traumatic brain injury and that fMRI can be used as an objective method to assess injury severity and subsequent recovery. Outside of his work with athletes, he is now using his research findings for the general traumatic brain injury population, including soldiers, athletes, motor vehicle accident victims, and children.

In recent years, Dr. Ptito has explored new treatment methods, namely high frequency repetitive transcranial magnetic stimulation to help alleviate post-concussion symptoms, including depression and cognitive impairment in mild traumatic brain injury patients. He also used a new treatment approach, tongue stimulation neuromodulation, in combination with intensive physical therapy, for improving gait and balance after mild to moderate head injury.

A question, a comment, need of information?

You can contact us here and leave us a message directly